Buy Jyothy Laboratories; target of Rs 188: Sharekhan

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Sharekhan's research report on Jyothy Laboratories

Q3FY21 was yet another strong quarter for Jyothy Labs (JLL) with consolidated revenues growing by 13.3%yoy to Rs. 476.6 crore (led by a 15% volume growth) and OPM expanding by 100 bps to 16.8%; PAT growth stood at 18.5%. Personal care and dishwashing products clocked strong growth of 48% and 21% respectively, driving Q3 performance house hold insecticide (HI) segment too grew by ~10%. Higher demand for dishwashing and personal care products and expected improvement in growth of fabric care segment will help JLL post double-digit growth in coming quarters. OPM to sustain at 16-17% in the near to medium term..

Outlook

We raise our earnings estimates for FY2022/23 by 7-9% to factor in better-than-expected growth in personal care products and expected recovery in fabric care category. Stock trades at discounted valuation of 18.6x its FY2023E EPS; maintain Buy with revised PT of Rs. 188.

For all recommendations report, click here

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More